Showing results (61-70 of 333) with videos related to
Sort By:
Pageof 34
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.Blood Cancer Discovery|May 7, 2024
CAR T-cell Resistance to Oncogenic TransformationMarco Ruella, Carl H JuneBlood Cancer Discovery|June 26, 2026
BTK Degraders in Lymphoid Malignancies: New Modality, New Resistance Rules?Alberto J Arribas, Carlo Visco, Francesco BertoniBlood Cancer Discovery|July 8, 2026
Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid MalignanciesRongrong Chen, Haiqiong Zheng, Wenxin Wang, et al.Blood Cancer Discovery|July 23, 2026
LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical ModelsNathan A Brooks, Anna Skwarska, Vivian Salama, et al.Blood Cancer Discovery|June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II ExpressionGuangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.Blood Cancer Discovery|September 13, 2021
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional AnalysisVictoria E Wang, Bradley W Blaser, Ravi K Patel, et al.Blood Cancer Discovery|November 15, 2021
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic MalignanciesAntoni Ribas, Madhav V Dhodapkar, Katie M Campbell, et al.Blood Cancer Discovery|January 11, 2022
Cancer and COVID-19: On the Quest for Effective VaccinesMarwan Kwok, Edward F Fritsch, Catherine J WuBlood Cancer Discovery|January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic MalignanciesStefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.Pageof 34